Loading insider details...
Beta
Latest Form 4 (Aug 24, 2026): Sale of 298,853 STLN shares, $1.95M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Starling Oncology, Inc. (STLN) | Sale | 298,853 | $1.95M |
| Jul 29, 2026 | Oncology Institute, Inc. (TOI) | Grant/Award | 27,108 | n/a |
| Dec 16, 2025 | Oncology Institute, Inc. (TOI) | Sale | 13,333 | $50.3K |
| Nov 24, 2025 | Oncology Institute, Inc. (TOI) | Grant/Award | 41,667 | n/a |
| Aug 21, 2025 | Oncology Institute, Inc. (TOI) | Sale | 20,221 | $82.1K |
| Jun 5, 2025 | Oncology Institute, Inc. (TOI) | Exercise/Conversion | 684,528 | $581.8K |
| Mar 28, 2025 | Oncology Institute, Inc. (TOI) | Purchase | 9,056 | $9.4K |
| Dec 2, 2024 | Oncology Institute, Inc. (TOI) | Other (see footnotes) | 353,450 | n/a |
| Nov 25, 2024 | Oncology Institute, Inc. (TOI) | Grant/Award | 44,000 | n/a |
| Jun 20, 2024 | Oncology Institute, Inc. (TOI) | Disposition to Issuer | 18,121 | $8.3K |